- Home
- FRO vs ACLX Comparison
FRO vs ACLX Comparison
Compare FRO & ACLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FRO
- ACLX
- Stock Information
- Founded
- FRO 1985
- ACLX 2015
- Country
- FRO Cyprus
- ACLX United States
- Employees
- FRO N/A
- ACLX N/A
- Industry
- FRO Marine Transportation
- ACLX Biotechnology: Pharmaceutical Preparations
- Sector
- FRO Consumer Discretionary
- ACLX Health Care
- Exchange
- FRO Nasdaq
- ACLX Nasdaq
- Market Cap
- FRO 4.0B
- ACLX 3.7B
- IPO Year
- FRO N/A
- ACLX 2022
- Fundamental
- Price
- FRO $18.99
- ACLX $63.00
- Analyst Decision
- FRO Strong Buy
- ACLX Strong Buy
- Analyst Count
- FRO 3
- ACLX 14
- Target Price
- FRO $23.33
- ACLX $111.42
- AVG Volume (30 Days)
- FRO 3.3M
- ACLX 605.3K
- Earning Date
- FRO 05-23-2025
- ACLX 08-07-2025
- Dividend Yield
- FRO 7.05%
- ACLX N/A
- EPS Growth
- FRO N/A
- ACLX N/A
- EPS
- FRO 1.56
- ACLX N/A
- Revenue
- FRO $1,899,854,000.00
- ACLX $76,809,000.00
- Revenue This Year
- FRO N/A
- ACLX N/A
- Revenue Next Year
- FRO $18.09
- ACLX $112.68
- P/E Ratio
- FRO $12.50
- ACLX N/A
- Revenue Growth
- FRO 0.88
- ACLX N/A
- 52 Week Low
- FRO $12.40
- ACLX $47.86
- 52 Week High
- FRO $26.53
- ACLX $107.37
- Technical
- Relative Strength Index (RSI)
- FRO 56.48
- ACLX 47.45
- Support Level
- FRO $18.42
- ACLX $64.77
- Resistance Level
- FRO $19.86
- ACLX $66.73
- Average True Range (ATR)
- FRO 0.64
- ACLX 2.89
- MACD
- FRO 0.09
- ACLX -0.35
- Stochastic Oscillator
- FRO 65.28
- ACLX 25.18
About FRO Frontline Plc
Frontline PLC is an international shipping company engaged in the seaborne transportation of crude oil and oil products. Group operates through the tankers segment. The tankers segment includes crude oil tankers and product tankers. Its geographical area of operation includes Arabian Gulf, West African, the North Sea, and the Caribbean. Frontline earns revenue through voyage charters, time charters, and a finance lease. It is also involved in the charter, purchase, and sale of vessels.
About ACLX Arcellx Inc.
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.